SEC Section 16 - Callout Image

 

Welcome to King’s SEC Section 16 Reports

These links will retrieve copies of Section 16 reports (Forms 3, 4 and 5) that the directors and executive officers of King Pharmaceuticals, Inc. have filed with the United States Securities and Exchange Commission’s EDGAR system on or after July 1, 2003.

A complete list of these Section 16 filings is available. Also available is a list of filings that King has made with the SEC.

Please call (908) 429-6000 extension 58905 with questions, comments, or requests for additional information.

Board Members

Brian A. Markison

President and Chief Executive Officer and Chairman of the Board

03/25/2009 Form Type 4
03/24/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
09/02/2008 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/18/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
03/22/2006 Form Type 4
10/20/2005 Form Type 4
07/16/2004 Form Type 4
03/09/2004 Form Type 4
03/09/2004 Form Type 3

Joseph Squicciarino

Chief Financial Officer

03/25/2009 Form Type 4
03/24/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
07/01/2008 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/18/2007 Form Type 4
07/06/2007 Form Type 4
05/17/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
10/04/2006 Form Type 4
03/22/2006 Form Type 4
10/20/2005 Form Type 4
07/06/2005 Form Type 3

James W. Elrod

General Counsel and Secretary

03/25/2009 Form Type 4
03/12/2009 Form Type 4
02/24/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/03/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
03/22/2006 Form Type 4
03/03/2006 Form Type 3

Frederick Brouillette, Jr.

Corporate Compliance Officer

03/25/2009 Form Type 4
03/24/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
09/02/2008 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/18/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
03/22/2006 Form Type 4
10/20/2005 Form Type 4
03/17/2004 Form Type 4
08/08/2003 Form Type 3

Stephen J. Andrzejewski

Chief Commercial Operations Officer

03/25/2009 Form Type 4
03/24/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
06/05/2008 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/18/2007 Form Type 4
05/17/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
03/22/2006 Form Type 4
10/20/2005 Form Type 4
03/25/2005 Form Type 3

Eric G. Carter

Chief Science Officer

03/25/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/03/2007 Form Type 4
03/23/2007 Form Type 4
02/26/2007 Form Type 3
02/26/2007 Form Type 4

Eric J. Bruce

President, Animal Health

03/25/2009 Form Type 4
03/24/2009 Form Type 4
03/12/2009 Form Type 4
02/19/2009 Form Type 4
01/22/2009 Form Type 4/A
01/21/2009 Form Type 4
09/02/2008 Form Type 4
03/27/2008 Form Type 4
02/22/2008 Form Type 4
12/18/2007 Form Type 4
03/23/2007 Form Type 4
02/28/2007 Form Type 4
03/22/2006 Form Type 4
10/20/2005 Form Type 4
06/21/2005 Form Type 3

Ted G. Wood

Lead Independent Director

05/19/2009 Form Type 4
05/19/2008 Form Type 4
05/02/2007 Form Type 4
10/04/2006 Form Type 4
05/02/2006 Form Type 4
05/02/2005 Form Type 4
05/03/2004 Form Type 4
03/17/2004 Form Type 4
02/05/2004 Form Type 5
09/03/2003 Form Type 3

Earnest W. Deavenport, Jr.

Director

05/19/2009 Form Type 4
05/19/2008 Form Type 4
05/02/2007 Form Type 4
10/04/2006 Form Type 4
05/02/2006 Form Type 4
05/03/2005 Form Type 4
05/02/2005 Form Type 4
08/06/2003 Form Type 4

Elizabeth M. Greetham

Director

05/19/2009 Form Type 4
05/19/2008 Form Type 4
05/02/2007 Form Type 4
10/04/2006 Form Type 4
05/02/2006 Form Type 4
05/02/2005 Form Type 4
05/03/2004 Form Type 4
03/17/2004 Form Type 4
02/17/2004 Form Type 3

Philip A. Incarnati

Director

05/19/2009 Form Type 4
05/19/2008 Form Type 4
05/02/2007 Form Type 4
11/03/2006 Form Type 3
11/03/2006 Form Type 4

Gregory D. Jordan

Director

05/19/2009 Form Type 4
05/19/2008 Form Type 4
05/02/2007 Form Type 4
10/04/2006 Form Type 4
05/02/2006 Form Type 4
05/02/2005 Form Type 4
05/03/2004 Form Type 4
08/06/2003 Form Type 4

R. Charles Moyer

Director

05/19/2009 Form Type 4
12/03/2008 Form Type 4
05/19/2008 Form Type 4
05/05/2008 Form Type 4
09/05/2007 Form Type 4
05/02/2007 Form Type 4
10/04/2006 Form Type 4
05/18/2005 Form Type 4
05/03/2004 Form Type 4
08/06/2003 Form Type 4

D. Greg Rooker

Director

05/19/2009 Form Type 4
09/12/2008 Form Type 4/A
05/19/2008 Form Type 4
04/10/2008 Form Type 4
02/14/2008 Form Type 5
05/02/2007 Form Type 4
02/14/2007 Form Type 4
01/18/2007 Form Type 4
10/04/2006 Form Type 4
05/02/2006 Form Type 4
01/19/2006 Form Type 4
12/21/2005 Form Type 4
05/02/2005 Form Type 4
02/14/2005 Form Type 5
12/14/2004 Form Type 4
05/03/2004 Form Type 4
02/17/2004 Form Type 5/A
02/13/2004 Form Type 4
02/13/2004 Form Type 5
08/06/2003 Form Type 4